Our Verification Process
Quality Is Built in Layers.
Verification starts before we purchase.
Quality cannot be established by a Certificate of Analysis alone. It begins with selecting capable manufacturers, continues through structured supplier qualification, is confirmed through independent analytical testing, and is maintained through continuous monitoring. AxonPeptide separates these responsibilities into distinct layers so that no single organization, laboratory, or document carries the entire weight of trust.
Verification starts before we purchase.
Independent laboratory testing is only one component of our quality framework — not the first one.
Before a manufacturer becomes an approved source, Axon Research Supply conducts a structured qualification process that evaluates manufacturing capability, quality systems, documentation practices, analytical consistency, and long-term reliability. Only manufacturers that satisfy those supplier-qualification standards are eligible to enter the AxonPeptide verification program. Once material is acquired, every production lot then undergoes independent analytical review before it is considered for release.
We build it this way because quality is not created by testing. Testing confirms that a specific lot meets specification. Supplier qualification helps determine whether that performance can be consistently reproduced. Each layer below is deliberately held by a different party, so that trust never rests on a single certificate.
Two independent layers of assurance.
Every material distributed by AxonPeptide originates from a manufacturer qualified through the Axon Research Supply Supplier Qualification Program — and every individual lot is then independently verified through our multi-laboratory analytical network.
This produces two distinct layers of quality assurance that answer two different questions. Supplier qualification asks whether the source is structurally capable of producing conforming material, lot after lot. Lot-level verification asks whether this specific batch, in front of us today, meets specification. Single-source testing creates single-point-of-failure risk in a category where documentation transparency matters. By distributing responsibility across a qualifying authority and multiple independent labs operating under different ownership, instrumentation, and methodology, we create structural accountability that no single certificate can provide on its own.
Testing tells us whether a lot meets specification. Supplier qualification tells us whether a manufacturer is capable of producing lots that consistently meet specification. We believe researchers deserve both.
Primary molecule-specific validation.
Every batch first goes through documentation review and molecule-specific testing through ARS Labs before anything can move forward in the release process.
ARS Labs
Every batch receives a panel of analytical tests scoped to the compound:
- Glutathione products may undergo additional oxidation review.
- 5-Amino-1MQ (iodide salt) may receive moisture-content analysis.
- Larger-chain GLP compounds may undergo expanded sampling due to higher distribution velocity.
ARS Labs operates as an independent research-focused analytical laboratory led by qualified scientific researchers and is designed to prioritize deeper analytical review rather than functioning as a high-volume certificate-generation facility. ARS Labs is independently operated, with separation from AxonPeptide enforced by the Medical Stewardship Council.
A note on accreditation. ARS Labs is not currently positioned as a commercial laboratory accredited under ISO 9001 or ISO/IEC 17025. Its analytical framework is, however, designed around the principles emphasized in both standards — ISO 9001 for quality management system structure (document control, corrective action, internal review), and ISO/IEC 17025 for laboratory competence (instrument validation, traceability, method controls, and quality review of analytical work). Alignment with these principles is operational; formal accreditation is not claimed.
Independent cross-verification.
After batches clear Phase I, a randomized subset is selected for independent secondary verification through either Kovera Labs or Freedom Diagnostics — an additional integrity checkpoint on both our testing process and broader supply chain consistency.
One of AxonPeptide's secondary validation partners. After batches clear primary review, a randomized subset is routed to Kovera as part of Axon's ongoing quality control model.
- Validate consistency across released batches
- Strengthen quality oversight
- Reduce dependence on a single analytical source
- Create additional accountability within the supply chain
An additional independent verification layer within Axon's quality model. Select randomized batches may be routed through Freedom Diagnostics depending on product category, validation needs, and broader quality assurance initiatives.
- Additional analytical redundancy
- Broader verification oversight
- Stronger long-term batch monitoring
- Continuous supply chain consistency review
Scientific stewardship.
All analytical work is reviewed internally before release by an independent Medical Stewardship Council. Their role is to review testing documentation and ensure materials meet our release standards.
The Council's mandate is documentation review and release standards — not clinical, dosing, or therapeutic guidance. It also enforces the structural separation between AxonPeptide and ARS Labs.
If a batch fails our standards at any point, it does not get released. We absorb the loss and discard the material.
Supplier qualification isn’t a one-time event.
Approved suppliers do not become permanent by default. They remain under continuous review through the Axon Research Supply Supplier Qualification Program.
Sourcing decisions are informed by analytical evidence, not commercial convenience. The goal is not only to catch failures at release — it is to reduce the probability that failures occur in the first place, by sourcing from manufacturers whose process consistency has been established and is being continuously monitored. The full framework lives with our supply-chain authority: Axon Research Supply.
Why we built it this way.
Many companies in this category rely on a single COA from a single source. We intentionally built a layered model because we believe research materials deserve:
- Qualified manufacturers, not just tested lots
- Independent verification layers
- Better traceability
- Greater transparency
- Continuous supplier & batch review
- Less reliance on single-point-failure systems
No testing model can eliminate all uncertainty in this category. Our goal is not to claim certainty — it is to provide more transparency, stronger documentation, and multiple layers of independent review so researchers can make more informed decisions.
Verification you can review.
AxonVerified is our public-facing documentation portal where customers can review lot-specific certificates of analysis, batch documentation, verification records, and educational materials.